![Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124719315013-gr2.jpg)
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect
![Post‐transcriptional control of immune responses and its potential application - Yoshinaga - 2019 - Clinical & Translational Immunology - Wiley Online Library Post‐transcriptional control of immune responses and its potential application - Yoshinaga - 2019 - Clinical & Translational Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/714502e9-30de-4bfd-aec0-cd605f741b4a/cti21063-fig-0001-m.jpg)
Post‐transcriptional control of immune responses and its potential application - Yoshinaga - 2019 - Clinical & Translational Immunology - Wiley Online Library
![RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular Pharmacology RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular Pharmacology](https://molpharm.aspetjournals.org/sites/default/files/styles/medium/public/highwire/molpharm/92/6.cover-source.jpg?itok=feE1Itzb)
RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular Pharmacology
![Alternative molecular formats and therapeutic applications for bispecific antibodies - ScienceDirect Alternative molecular formats and therapeutic applications for bispecific antibodies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S016158901500005X-gr1.jpg)
Alternative molecular formats and therapeutic applications for bispecific antibodies - ScienceDirect
![Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo | Scientific Reports Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-017-10420-z/MediaObjects/41598_2017_10420_Fig1_HTML.jpg)
Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo | Scientific Reports
![Frontiers | IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice | Immunology Frontiers | IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice | Immunology](https://www.frontiersin.org/files/Articles/555984/fimmu-11-01516-HTML/image_m/fimmu-11-01516-g001.jpg)
Frontiers | IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice | Immunology
![Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124719315013-fx1.jpg)